机器人辅助经肛门全直肠系膜切除术与腹腔镜辅助经肛门全直肠系膜切除术治疗中低位直肠癌的标本质量、并发症发生率及长期肿瘤学结果相似。
Robotic male and laparoscopic female sphincter-preserving total mesorectal excision of mid-low rectal cancer share similar specimen quality, complication rates and long-term oncological outcomes.
机构信息
Bogazici Academy for Clinical Sciences, Istanbul, Turkey.
Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
出版信息
J Robot Surg. 2023 Aug;17(4):1637-1644. doi: 10.1007/s11701-023-01558-2. Epub 2023 Mar 21.
The aim of this study was to compare perioperative and long-term oncological outcomes between laparoscopic sphincter-preserving total mesorectal excision in female patients (F-Lap-TME) and robotic sphincter-preserving total mesorectal excision in male patients (M-Rob-TME) with mid-low rectal cancer (RC). A retrospective analysis of a prospectively maintained database was performed. 170 cases (F-Lap-TME: 60 patients; M-Rob-TME: 110 patients) were performed by a single surgeon (January 2011-January 2020). Clinical characteristics did not differ significantly between the two groups. Operating time was longer in M-Rob-TME than in F-Lap-TME group (185.3 ± 28.4 vs 124.5 ± 35.8 min, p < 0.001). There was no conversion to open surgery in both groups. Quality of mesorectum was complete/near-complete in 58 (96.7%) and 107 (97.3%) patients of F-Lap-TME and M-Rob-TME (p = 0.508), respectively. Circumferential radial margin involvement was observed in 2 (3.3%) and 3 (2.9%) in F-Lap-TME and M-Rob-TME patients (p = 0.210), respectively. Median length of follow-up was 62 (24-108) months in the F-Lap-TME and 64 (24-108) months in the M-Rob-TME group. Five-year overall survival rates were 90.5% in the F-Lap-TME and 89.6% in the M-Rob-TME groups (p = 0.120). Disease-free survival rates in F-Lap-TME and M-Rob-TME groups were 87.5% and 86.5% (p = 0.145), respectively. Local recurrence rates were 5% (n = 3) and 5.5% (n = 6) (p = 0.210), in the F-Lap-TME and M-Rob-TME groups, respectively. The robotic technique can potentially overcome some technical challenges related to the pelvic anatomical difference between sex compared to laparoscopy. Laparoscopic and robotic approach, respectively in female and male patients provide similar surgical specimen quality, perioperative outcomes, and long-term oncological results.
本研究旨在比较女性患者腹腔镜保肛全直肠系膜切除术(F-Lap-TME)与男性患者机器人保肛全直肠系膜切除术(M-Rob-TME)治疗中低位直肠癌(RC)的围手术期和长期肿瘤学结果。对一个前瞻性维护的数据库进行了回顾性分析。由一名外科医生(2011 年 1 月至 2020 年 1 月)进行了 170 例手术(F-Lap-TME:60 例;M-Rob-TME:110 例)。两组患者的临床特征无显著差异。M-Rob-TME 组的手术时间长于 F-Lap-TME 组(185.3±28.4 分钟比 124.5±35.8 分钟,p<0.001)。两组均无中转开腹手术。F-Lap-TME 和 M-Rob-TME 组的直肠系膜完整/近完整率分别为 58(96.7%)和 107(97.3%)(p=0.508)。F-Lap-TME 和 M-Rob-TME 组的环周切缘阳性率分别为 2(3.3%)和 3(2.9%)(p=0.210)。F-Lap-TME 组的中位随访时间为 62(24-108)个月,M-Rob-TME 组为 64(24-108)个月。F-Lap-TME 组和 M-Rob-TME 组的 5 年总生存率分别为 90.5%和 89.6%(p=0.120)。F-Lap-TME 和 M-Rob-TME 组的无病生存率分别为 87.5%和 86.5%(p=0.145)。F-Lap-TME 和 M-Rob-TME 组的局部复发率分别为 5%(n=3)和 5.5%(n=6)(p=0.210)。与腹腔镜相比,机器人技术可能克服了与性别相关的盆腔解剖差异相关的一些技术挑战。在女性和男性患者中,腹腔镜和机器人方法分别提供了相似的手术标本质量、围手术期结果和长期肿瘤学结果。